Obesity is a common risk factor for non-alcoholic fatty liver disease (NAFLD). Currently, there are no specific treatments against NAFLD. Thus, examining any molecule with potential benefits against this condition emerged melatonin as a molecule that influences metabolic dysfunctions. The aim of this study was to determine whether melatonin would function against NAFDL, studying morphological, ultrastuctural and metabolic markers that characterize the liver of ob/ob mice.
Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease
STACCHIOTTI, Alessandra;FAVERO, Gaia;LAVAZZA, Antonio;RODELLA, Luigi Fabrizio;REZZANI, Rita
2016-01-01
Abstract
Obesity is a common risk factor for non-alcoholic fatty liver disease (NAFLD). Currently, there are no specific treatments against NAFLD. Thus, examining any molecule with potential benefits against this condition emerged melatonin as a molecule that influences metabolic dysfunctions. The aim of this study was to determine whether melatonin would function against NAFDL, studying morphological, ultrastuctural and metabolic markers that characterize the liver of ob/ob mice.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
StacchiottietalPlosOne2016.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Full Text
Licenza:
Dominio pubblico
Dimensione
16.21 MB
Formato
Adobe PDF
|
16.21 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
